Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the anabolic potentials of insulin may be
used to reverse the catabolic effects of hemodialysis in non-diabetic patients with end-stage
renal failure.